Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancer

Barbara Burtness, M. Gibson, B. Egleston, R. Mehra, L. Thomas, R. Sipples, M. Quintanilla, J. Lacy, S. Watkins, J. R. Murren, A. A. Forastiere

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences